Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 2/5/2026Novo Nordisk Reports First Decline in Ozempic Sales in Greater China
  • 2/5/2026Fosun Secures Priority Review in China for Luvometinib's New Indicatio...
  • 2/5/2026AmCham China Hosts US FDA Delegation to Strengthen Regulatory Dialogue
  • 2/5/2026Ascentage Secures China IND Clearance for Next-Gen BTK Degrader APG-32...
  • 2/5/2026Evogene and Lishan Biopharma Partner to Develop Microbiome Therapy for...
  • 2/5/2026Everest Medicines Licenses Micot's MT1013 for SHPT in China and Asia-P...
  • 2/5/2026Angitia Biopharma Raises $130M in Series D Financing to Advance Pipeli...
  • 2/5/2026Eisai Secures Exclusive Rights to Henlius' Anti-PD-1 Antibody Serpluli...
  • 2/5/2026iMBioRay Raises Nearly CNY 200M Series B to Advance NK Cell Therapy P...
  • 2/5/2026Shanghai Pharma Exits BMS China, Closing a Chapter for JV Pharma in Ch...
  • 2/5/20262026 National Conference on Drug Registration and Post-Market Regulati...
  • 2/5/2026CDE Issues Trial Guideline for Neuropathic Pain Drug Development
  • 2/5/2026CDE Issues Technical Guideline for Clinical Trials of Chronic Insomnia...
  • 2/4/2026Innovent Advances IL-15 Antibody IBI3013 Into Clinical Trials for Viti...
  • 2/4/2026China Clears BeBetter Med Dual-Target siRNA Therapy for Combined Hyper...
  • 2/4/2026Vertex Takes Global Control of WuXi Biologics Trispecific T-Cell Engag...
  • 2/4/2026Novartis Secures Global Rights to SciNeuro’s Next-Gen Alzheimer’s An...
  • 2/4/2026Chia Tai Tianqing's Anlotinib New Indication Application Rejected
  • 2/4/2026China Gene‑Editing Startup AccurEdit Raises $75M to Advance Promising...
  • 2/4/2026WuXi Biologics and Sinorda Join Forces to Develop Bispecific Antibody ...
  • 2/4/2026Almirall's Seysara Approved in China for Moderate-to-Severe Acne
  • 2/4/2026Ant Group's AI Health Chatbot Surges in Popularity Amid China's Overbu...
  • 2/4/2026China's Health Insurance Market Poised for $596B Surge by 2033
  • 2/4/2026Bayer's Nubeqa Gains Third Approval in China for Advanced Prostate Can...
  • 2/4/2026CMS Gets Green Light from NMPA to Launch Trials for Novel Kidney Disea...
  • 2/3/2026NMPA Logs Wave of Novel Drug Approvals and Clinical Trial Clearances L...
  • 2/3/2026Beijing-Based PrimeGenX Therapeutics' HKSE IPO Application Accepted
  • 2/3/2026HSG Completes Global Acquisition of Avelox and Launches Anti-Infective...
  • 2/3/2026New Indication for Novartis' Secukinumab in Non-Radiographic Axial Spo...
  • 2/3/2026Zonsen PepLib Signs Global Peptide R&D Deal with Eli Lilly
  • Page:7/61 Total number of articles:1809: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group